GlycoFlex Stage 3 Tablets (Canada)
This treatment applies to the following species:Ultimate Strength
VETERINARIAN FORMULATED
JOINT SUPPORT
A GlycOmega™ Perna product for joint and connective tissue support
NN.C7Y6
CANINE FORMULA
VETERINARY HEALTH PRODUCT
DOGS
ALL WEIGHT RANGES
PRODUCT DETAILS:
GlycoFlex® 3 Bite-Sized Tablets represents Stage 3 of our comprehensive stage of life program for the support and maintenance of healthy joints in dogs. These delicious chicken liver flavoured tablets are recommended by veterinarians for dogs of all weight ranges.
PRODUCT FACTS:
For use in dogs only.
Active Ingredients Per 1 Tablet
Glucosamine HCl (Shrimp and Crab) |
1000 mg |
Methylsulfonylmethane (MSM) |
1000 mg |
Perna canaliculus (GlycOmega™ brand Green-Lipped Mussel) |
600 mg |
N,N-Dimethylglycine HCl (DMG) |
100 mg |
dl-alpha Tocopheryl Acetate (Vitamin E) |
22.5 mg (50 IU) |
Calcium Ascorbate Acid (Vitamin C) |
30 mg |
Manganese (proteinate) |
10 mg |
Grape Seed Extract |
5 mg |
L-Glutathione |
2 mg |
Selenium (Sodium Selenite) |
0.002 mg |
Inactive Ingredients
brewers yeast, cellulose, dicalcium phosphate, natural imitation roast chicken flavor, silicon dioxide, stearic acid.
GlycOmega™ is a trademark of Aroma New Zealand LTD.
Directions For Use
Initial (4 - 6 Weeks):
Up to 14 kg: |
1/2 tablet daily |
14 - 27 kg: |
1 tablet daily |
27 - 45 kg: |
2 tablets daily |
Over 45 kg: |
2 1/2 tablets daily |
Maintenance (After initial period):
Up to 14 kg: |
1/2 tablet every other day |
14 - 27 kg: |
1/2 tablet daily |
27 - 45 kg: |
1 tablet daily |
Over 45 kg: |
1 1/2 tablets daily |
If giving more than 1 tablet daily, divide between AM and PM.
Duration of Use: For use longer than 8 weeks consult a veterinarian.
Cautions: Do not use in animals with bleeding disorders or in animals with lung or liver disease unless directed by a veterinarian. Do not use in pregnant or lactating animals. Not for long term use, unless directed by a veterinarian. Administer during or after the animal has eaten to reduce incidence of gastrointestinal upset. For animal use only. Some pets may consider this a treat. In case of accidental overdose, contact a veterinarian immediately.
Warning
Keep out of reach of children.Store in a cool, dry place.
Manufactured by: VetriScience® Laboratories, A Division of FoodScience® LLC, 929 Harvest Lane, Williston, VT 05495
www.vetriscience.com, 1-800-882-9993
Distributed by:
Dechra Veterinary Products Inc., 1 Holiday Avenue, East Tower, Suite 345, Pointe-Claire, Québec, Canada H9R 5N3
1-855-332-9334
90 BITE-SIZED CHEWABLE TABLETS |
09FY887.090 |
0922 |
CPN: 1786076.0
1 HOLIDAY AVE., WEST TOWER SUITE 300, POINT-CLAIRE, QC, H9R 5N3
Toll-Free: | 855-332-9334 | |
Technical Services: | 855-332-9334 | |
Technical Services Email: | technical.ca@dechra.com | |
Website: | www.dechra.ca |
![]() |
THIS SERVICE AND DATA ARE PROVIDED "AS IS". Animalytix assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the Animalytix service and data. See the Terms of Use for further details. |
Copyright © 2025 Animalytix LLC. Updated: 2025-05-29
Elsewhere on our site...
Wegovy
Wegovy (semaglutide) an FDA-approved weekly injection for weight loss and to reduce heart risks ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Zepbound
Zepbound (tirzepatide) is an FDA-approved weekly injection for weight loss and obstructive sleep ...
Trulicity
Trulicity is an injectable diabetes medicine that is used together with diet and exercise to ...
Lantus
Lantus is a long acting form of insulin used to treat type 1 or type 2 diabetes. Learn about side ...
Tresiba
Tresiba (insulin degludec) is used to treat diabetes mellitus. Includes Tresiba side effects ...
Phentermine
Phentermine is an appetite suppressant used together with diet and exercise to treat obesity. Learn ...
Semaglutide
Semaglutide is a GLP-1 agonist used for weight loss, type 2 diabetes, and reducing cardiovascular ...